Tag: aSAH
Why mechanical angioplasty deserves a place in the vasospasm treatment algorithm
As part of a PhD programme supervised by Boris Lubicz, Adrien Guenego (both Brussels, Belgium) recently conducted the first prospective randomised trial directly evaluating...
Aurenar gains US FDA breakthrough designation for neuromodulation therapy designed to...
Aurenar has announced that the US Food and Drug Administration (FDA) has granted a Breakthrough Device designation to its V-Link system for the reduction...
Female sex, disease severity and vasospasm among predictors of post-SAH delayed...
A meta-analysis of more than 4,500 patients, presented recently at the 16th World Stroke Congress (WSC; 23–26 October, Abu Dhabi, United Arab Emirates), has revealed...
US and Chinese experts introduce new aneurysmal subarachnoid haemorrhage guidelines
Expert groups from the USA and China have separately introduced new guidelines relating to the management of aneurysmal subarachnoid haemorrhage (aSAH). The updated guidelines—spearheaded...
Vesalio announces successful initial use of NeVa VS device in USA
Vesalio has announced the successful initial use of its NeVa VS device in the USA for the treatment of post-aneurysmal subarachnoid haemorrhage (aSAH) cerebral...
Vesalio announces US FDA approval of NeVa VS to treat cerebral...
Vesalio has announced US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for commercialisation of its NeVa VS device, which is indicated...
